PMC full text:

J Altern Complement Med. 2012 Apr; 18(4): 354–362.

doi: 10.1089/acm.2011.0408

Copyright/License ►Request permission to reuse: Copyright 2012, Mary Ann Liebert, Inc.

Table 3.

Regression Model Results^{^a}

	IC^{^b}	UC^{^b}	p-Value
Roland-Morris	0.89 (0.61, 1.17)	0.32 (−0.004, 0.64)	0.02
Bothersomeness	0.39 (0.29, 0.48)	0.05 (−0.08, 0.19)	0.002
Pain	0.30 (0.24, 0.37)	0.04 (−0.10, 0.19)	0.001
Worst activity	0.43 (0.33, 0.54)	0.10 (−0.06, 0.25)	0.01
Worry	0.21 (0.06, 0.36)	0.10 (−0.04, 0.25)	0.34
SF-12 Physical	1.27 (0.97, 1.58)	0.38 (−0.10, 0.85)	0.01
SF-12 Mental	0.17 (−0.41, 0.75)	0.23 (−0.09, 0.54)	0.97
Days in bed	0.05 (−0.005, 0.10)	0.04 (−0.04, 0.13)	0.85
Days at home	0.17 (0.06, 0.29)	0.14 (−0.005, 0.29)	0.68
Reduced activity days	0.28 (0.16, 0.39)	0.19 (0.07, 0.30)	0.41

^aDuring the 12-week treatment period, adjusted for baseline level.

^bEstimated slope (β) and its 95% confidence interval per change in outcome per week in each treatment group.

IC, integrative care; UC, usual care; SF-12, Medical Outcomes Study Short-Form.